Cargando…
Case Report and Literature Review: Diagnosis, Tailored Genetic Counseling and Cancer Prevention for a Locally Advanced dMMR/MSI-H/TMB-H Lung Cancer Patient With Concurrent Lynch Syndrome Mediated by a Rare PMS2 Splicing Variant (c.1144+1G>A)
Lynch syndrome (LS) is a cancer-predisposing genetic disease mediated by pathogenic mutations in DNA mismatch repair (MMR) genes MLH1, MSH2, MSH6, and PMS2. Accumulating evidence demonstrates that there is significant biological heterogeneity across MMR genes. Compared to MLH1 and MSH2, PMS2 variant...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804326/ https://www.ncbi.nlm.nih.gov/pubmed/35116055 http://dx.doi.org/10.3389/fgene.2021.799807 |
_version_ | 1784643052866895872 |
---|---|
author | Han, Quanli Liu, Si Cui, Zhi Wang, Qi Ma, Tonghui Jiang, Liwen Li, Xiaomo Dai, Guanghai |
author_facet | Han, Quanli Liu, Si Cui, Zhi Wang, Qi Ma, Tonghui Jiang, Liwen Li, Xiaomo Dai, Guanghai |
author_sort | Han, Quanli |
collection | PubMed |
description | Lynch syndrome (LS) is a cancer-predisposing genetic disease mediated by pathogenic mutations in DNA mismatch repair (MMR) genes MLH1, MSH2, MSH6, and PMS2. Accumulating evidence demonstrates that there is significant biological heterogeneity across MMR genes. Compared to MLH1 and MSH2, PMS2 variant carriers have a much lower risk for LS-related cancers. Tumors in MLH1 and MSH2 variant carriers often display MMR deficiency (dMMR) and/or high microsatellite instability (MSI-H), two predictive biomarkers for immunotherapy efficacy. However, tumors in PMS2 variant carriers are largely microsatellite stable (MSS) instead of MSI. Therefore, the optimal management of cancer patients with LS requires the integration of disease stage, MMR gene penetrance, dMMR/MSI status, and tumor mutational burden (TMB). In this work, we presented a locally advanced lung cancer patient with dMMR/MSI-H/TMB-H tumor and selective loss of PMS2 by immunohistochemistry. Germline testing revealed a rare PMS2 splicing variant (c.1144+1G>A) in the proband and his healthy daughter. The diagnosis of LS was made based on genetic analysis of this variant and literature review. Given the incomplete penetrance of PMS2, the proband and the carrier received tailored genetic counseling. To reduce cancer risk, the proband received four cycles of nivolumab plus chemotherapy and achieved a disease-free survival of sixteen months. |
format | Online Article Text |
id | pubmed-8804326 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-88043262022-02-02 Case Report and Literature Review: Diagnosis, Tailored Genetic Counseling and Cancer Prevention for a Locally Advanced dMMR/MSI-H/TMB-H Lung Cancer Patient With Concurrent Lynch Syndrome Mediated by a Rare PMS2 Splicing Variant (c.1144+1G>A) Han, Quanli Liu, Si Cui, Zhi Wang, Qi Ma, Tonghui Jiang, Liwen Li, Xiaomo Dai, Guanghai Front Genet Genetics Lynch syndrome (LS) is a cancer-predisposing genetic disease mediated by pathogenic mutations in DNA mismatch repair (MMR) genes MLH1, MSH2, MSH6, and PMS2. Accumulating evidence demonstrates that there is significant biological heterogeneity across MMR genes. Compared to MLH1 and MSH2, PMS2 variant carriers have a much lower risk for LS-related cancers. Tumors in MLH1 and MSH2 variant carriers often display MMR deficiency (dMMR) and/or high microsatellite instability (MSI-H), two predictive biomarkers for immunotherapy efficacy. However, tumors in PMS2 variant carriers are largely microsatellite stable (MSS) instead of MSI. Therefore, the optimal management of cancer patients with LS requires the integration of disease stage, MMR gene penetrance, dMMR/MSI status, and tumor mutational burden (TMB). In this work, we presented a locally advanced lung cancer patient with dMMR/MSI-H/TMB-H tumor and selective loss of PMS2 by immunohistochemistry. Germline testing revealed a rare PMS2 splicing variant (c.1144+1G>A) in the proband and his healthy daughter. The diagnosis of LS was made based on genetic analysis of this variant and literature review. Given the incomplete penetrance of PMS2, the proband and the carrier received tailored genetic counseling. To reduce cancer risk, the proband received four cycles of nivolumab plus chemotherapy and achieved a disease-free survival of sixteen months. Frontiers Media S.A. 2022-01-18 /pmc/articles/PMC8804326/ /pubmed/35116055 http://dx.doi.org/10.3389/fgene.2021.799807 Text en Copyright © 2022 Han, Liu, Cui, Wang, Ma, Jiang, Li and Dai. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Genetics Han, Quanli Liu, Si Cui, Zhi Wang, Qi Ma, Tonghui Jiang, Liwen Li, Xiaomo Dai, Guanghai Case Report and Literature Review: Diagnosis, Tailored Genetic Counseling and Cancer Prevention for a Locally Advanced dMMR/MSI-H/TMB-H Lung Cancer Patient With Concurrent Lynch Syndrome Mediated by a Rare PMS2 Splicing Variant (c.1144+1G>A) |
title | Case Report and Literature Review: Diagnosis, Tailored Genetic Counseling and Cancer Prevention for a Locally Advanced dMMR/MSI-H/TMB-H Lung Cancer Patient With Concurrent Lynch Syndrome Mediated by a Rare PMS2 Splicing Variant (c.1144+1G>A) |
title_full | Case Report and Literature Review: Diagnosis, Tailored Genetic Counseling and Cancer Prevention for a Locally Advanced dMMR/MSI-H/TMB-H Lung Cancer Patient With Concurrent Lynch Syndrome Mediated by a Rare PMS2 Splicing Variant (c.1144+1G>A) |
title_fullStr | Case Report and Literature Review: Diagnosis, Tailored Genetic Counseling and Cancer Prevention for a Locally Advanced dMMR/MSI-H/TMB-H Lung Cancer Patient With Concurrent Lynch Syndrome Mediated by a Rare PMS2 Splicing Variant (c.1144+1G>A) |
title_full_unstemmed | Case Report and Literature Review: Diagnosis, Tailored Genetic Counseling and Cancer Prevention for a Locally Advanced dMMR/MSI-H/TMB-H Lung Cancer Patient With Concurrent Lynch Syndrome Mediated by a Rare PMS2 Splicing Variant (c.1144+1G>A) |
title_short | Case Report and Literature Review: Diagnosis, Tailored Genetic Counseling and Cancer Prevention for a Locally Advanced dMMR/MSI-H/TMB-H Lung Cancer Patient With Concurrent Lynch Syndrome Mediated by a Rare PMS2 Splicing Variant (c.1144+1G>A) |
title_sort | case report and literature review: diagnosis, tailored genetic counseling and cancer prevention for a locally advanced dmmr/msi-h/tmb-h lung cancer patient with concurrent lynch syndrome mediated by a rare pms2 splicing variant (c.1144+1g>a) |
topic | Genetics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804326/ https://www.ncbi.nlm.nih.gov/pubmed/35116055 http://dx.doi.org/10.3389/fgene.2021.799807 |
work_keys_str_mv | AT hanquanli casereportandliteraturereviewdiagnosistailoredgeneticcounselingandcancerpreventionforalocallyadvanceddmmrmsihtmbhlungcancerpatientwithconcurrentlynchsyndromemediatedbyararepms2splicingvariantc11441ga AT liusi casereportandliteraturereviewdiagnosistailoredgeneticcounselingandcancerpreventionforalocallyadvanceddmmrmsihtmbhlungcancerpatientwithconcurrentlynchsyndromemediatedbyararepms2splicingvariantc11441ga AT cuizhi casereportandliteraturereviewdiagnosistailoredgeneticcounselingandcancerpreventionforalocallyadvanceddmmrmsihtmbhlungcancerpatientwithconcurrentlynchsyndromemediatedbyararepms2splicingvariantc11441ga AT wangqi casereportandliteraturereviewdiagnosistailoredgeneticcounselingandcancerpreventionforalocallyadvanceddmmrmsihtmbhlungcancerpatientwithconcurrentlynchsyndromemediatedbyararepms2splicingvariantc11441ga AT matonghui casereportandliteraturereviewdiagnosistailoredgeneticcounselingandcancerpreventionforalocallyadvanceddmmrmsihtmbhlungcancerpatientwithconcurrentlynchsyndromemediatedbyararepms2splicingvariantc11441ga AT jiangliwen casereportandliteraturereviewdiagnosistailoredgeneticcounselingandcancerpreventionforalocallyadvanceddmmrmsihtmbhlungcancerpatientwithconcurrentlynchsyndromemediatedbyararepms2splicingvariantc11441ga AT lixiaomo casereportandliteraturereviewdiagnosistailoredgeneticcounselingandcancerpreventionforalocallyadvanceddmmrmsihtmbhlungcancerpatientwithconcurrentlynchsyndromemediatedbyararepms2splicingvariantc11441ga AT daiguanghai casereportandliteraturereviewdiagnosistailoredgeneticcounselingandcancerpreventionforalocallyadvanceddmmrmsihtmbhlungcancerpatientwithconcurrentlynchsyndromemediatedbyararepms2splicingvariantc11441ga |